Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.

Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno
{"title":"Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.","authors":"Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno","doi":"10.1016/j.pcad.2024.10.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the prospective dose-response association of accelerometer-measured moderate-to-vigorous physical activity (PA;MVPA) with all-cause mortality and cardiovascular disease (CVD) incidence.</p><p><strong>Methods: </strong>This prospective cohort of 76,074 participants from the UK Biobank study contained one week of individual accelerometer-based PA data collected between June 1, 2013 and December 23, 2015. Using restricted cubic splines to allow for potential non-linearity, we examined dose-response associations of MVPA with all-cause mortality and incident CVD, respectively.</p><p><strong>Results: </strong>The median follow-up time was 8.0 years (IQR 7.5-8.5). The dose-response association of MVPA with all-cause mortality and CVD showed a similar L-shaped association, with significant risk reductions already from 10 min of MVPA per week for all-cause mortality (hazard ratio [HR], 0.98 [95 % CI,0.98-0.99]) and 15 min per week for CVD incidence (HR, 0.99 [95 % CI,0.98-0.99]). Doing more MVPA was associated with further risk reduction, but beyond around 500 min per week the benefits levelled off at HR's around 0.6 to 0.7. The highest additional benefit of adding more minutes per week for all-cause mortality and CVD incidence were observed between 100 and 250 weekly minutes of MVPA. From this point forward, the mean risk reduction rates decreased and were close to 0 beyond 500 weekly minutes.</p><p><strong>Conclusions: </strong>Significant, but small, risk reductions in all-cause mortality and CVD incidence can be achieved with as little as 10 and 15 min of MVPA per week, respectively. However, public health organizations should promote the attainment of 250 min of MVPA per week (with 100 min as a possible first target for inactive individuals), as these thresholds are associated with the greatest efficiency. Beyond that, less pronounced risk reductions can be achieved by accumulating additional MVPA, with hardly any additional benefits beyond 500 weekly minutes.</p>","PeriodicalId":94178,"journal":{"name":"Progress in cardiovascular diseases","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in cardiovascular diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.pcad.2024.10.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the prospective dose-response association of accelerometer-measured moderate-to-vigorous physical activity (PA;MVPA) with all-cause mortality and cardiovascular disease (CVD) incidence.

Methods: This prospective cohort of 76,074 participants from the UK Biobank study contained one week of individual accelerometer-based PA data collected between June 1, 2013 and December 23, 2015. Using restricted cubic splines to allow for potential non-linearity, we examined dose-response associations of MVPA with all-cause mortality and incident CVD, respectively.

Results: The median follow-up time was 8.0 years (IQR 7.5-8.5). The dose-response association of MVPA with all-cause mortality and CVD showed a similar L-shaped association, with significant risk reductions already from 10 min of MVPA per week for all-cause mortality (hazard ratio [HR], 0.98 [95 % CI,0.98-0.99]) and 15 min per week for CVD incidence (HR, 0.99 [95 % CI,0.98-0.99]). Doing more MVPA was associated with further risk reduction, but beyond around 500 min per week the benefits levelled off at HR's around 0.6 to 0.7. The highest additional benefit of adding more minutes per week for all-cause mortality and CVD incidence were observed between 100 and 250 weekly minutes of MVPA. From this point forward, the mean risk reduction rates decreased and were close to 0 beyond 500 weekly minutes.

Conclusions: Significant, but small, risk reductions in all-cause mortality and CVD incidence can be achieved with as little as 10 and 15 min of MVPA per week, respectively. However, public health organizations should promote the attainment of 250 min of MVPA per week (with 100 min as a possible first target for inactive individuals), as these thresholds are associated with the greatest efficiency. Beyond that, less pronounced risk reductions can be achieved by accumulating additional MVPA, with hardly any additional benefits beyond 500 weekly minutes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加速计测量的体力活动与全因死亡率和心血管疾病发病率的剂量-反应关系:由 76,074 名参与者组成的前瞻性队列。
目的研究加速度计测量的中强度体力活动(PA;MVPA)与全因死亡率和心血管疾病(CVD)发病率的前瞻性剂量-反应关系:该前瞻性队列由英国生物库研究的76074名参与者组成,包含2013年6月1日至2015年12月23日期间收集的一周基于加速计的个人PA数据。利用限制性三次样条来考虑潜在的非线性,我们分别研究了MVPA与全因死亡率和心血管疾病发病率的剂量-反应关系:中位随访时间为 8.0 年(IQR 7.5-8.5)。MVPA 与全因死亡率和心血管疾病的剂量-反应关系显示出类似的 L 型关系,每周 10 分钟 MVPA 可显著降低全因死亡率的风险(危险比 [HR],0.98 [95 % CI,0.98-0.99]),每周 15 分钟可显著降低心血管疾病发病率的风险(HR,0.99 [95 % CI,0.98-0.99])。进行更多的 MVPA 与进一步降低风险有关,但超过每周约 500 分钟后,益处趋于平稳,HR 约为 0.6 至 0.7。每周增加 100 到 250 分钟 MVPA 对全因死亡率和心血管疾病发病率的额外益处最高。从这一点来看,平均风险降低率有所下降,在每周 500 分钟之后接近于 0:结论:只需每周分别进行 10 分钟和 15 分钟的 MVPA,就能显著降低全因死亡率和心血管疾病发病率的风险,但降幅较小。然而,公共卫生组织应提倡每周达到 250 分钟的 MVPA(对于不爱运动的人来说,100 分钟可能是第一目标),因为这些阈值与最大的效率相关。除此以外,通过累积更多的 MVPA 可以实现不太明显的风险降低,每周 500 分钟以上几乎没有额外的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cardiovascular outcomes among giant cell myocarditis compared with cardiac sarcoidosis: A propensity score-matched analysis. Assorted topics III 2024. Of meat & molecules. Safety outcomes of oral anticoagulants in patients with an indication of anti-coagulants after TAVR: A meta-analysis. Cardiovascular-kidney-metabolic syndrome - An integrative review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1